Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Main Inclusion Criteria:~* ≥ Age 12 years at the Screening Visit.~* History of asthma for 12 months prior to the Screening Visit.~* Documented use of an inhaled corticosteroid for at least 4 weeks prior to the Screening Visit.~* Steroid-requiring patient~* patients must demonstrate (1) an FEV1 of 40% to 80% (inclusive) of predicted normal values at both the Screening and Baseline Visits and (2) documented reversibility within 12 months of the Screening Visit, defined as a ≥ 15%~Main Exclusion Criteria:~* Life-threatening asthma within the past year or during the Run-In Period.~* History of systemic (oral or injectable) corticosteroid medication within 3 months before the Screening Visit.~* An upper or lower respiratory infection within 4 weeks prior to the Screening Visit or during the Run-In Period.~* Significant, non-reversible, pulmonary disease (e.g., chronic obstructive pulmonary disease \[COPD\], cystic fibrosis, bronchiectasis).~* A smoking history equivalent to 10 pack years (i.e., at least 1 pack of 20 cigarettes /day for 10 years or 10 packs/day for 1 year, etc.).~* Current smoking history within 12 months prior to the Screening Visit.~* Previous exposure to FlutiForm

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): FlutiForm 250/10ug
- 2 (Type: ACTIVE_COMPARATOR): SKP Fluticasone 250ug
- 3 (Type: ACTIVE_COMPARATOR): Flovent Fluticasone HFA

Based on this trial design, predict the completion outcome and termination type (if applicable).